2nd Feb 2006 07:00
Smith & Nephew Plc02 February 2006 Smith & Nephew - Finance Director Appointment 2 February 2006 Smith & Nephew plc (LSE: SN, NYSE: SNN) the global medical technology businessannounces today that after 15 years as Finance Director Peter Hooley will retirein mid 2006. Peter has made a major contribution to the development of thebusiness, both strategically and financially. The board is deeply appreciativeof his dedication to the business and his achievements in increasing shareholdervalue. The Board has conducted a thorough search process and is pleased to announcethat Adrian Hennah, currently Chief Financial Officer of Invensys plc, will beappointed to the board as Finance Director in June 2006. Chris O'Donnell, Chief Executive of Smith & Nephew commenting on thisappointment said "Peter and I have worked closely together since he first joinedSmith & Nephew and in particular during the successful restructuring of theGroup. His wise counsel and deep understanding of the business have played amajor part in growing Smith & Nephew into a worldwide leader in the medicaldevices sector. Adrian Hennah has all the characteristics we were looking for in a new FinanceDirector. He brings a combination of industrial and international experience,as well as deep financial skills. I welcome Adrian to the Board, to Smith &Nephew, and the talent and strength he will bring." There are no details relating to the appointment of Adrian Hennah that arerequired to be disclosed pursuant to paragraph 9.6.13 (1-6) of the ListingRules. Enquiries Investors Sir Christopher O'Donnell Tel: +44 (0) 20 7401 7646 Group Chief Executive Smith & Nephew Investors / Media Liz Hewitt Tel: +44 (0) 20 7401 7646 Group Director Corporate Affairs Smith & Nephew About Adrian Hennah Adrian Hennah (47) MA (Cantab) qualified with Price Waterhouse and worked as amanagement consultant for them before joining Glaxo in 1984 where his earlyroles included UK Finance and IT Director. He continued his career at Glaxo asGeneral Manager at Allen & Hanbury's and Director of Glaxo UK then acting as theglobal integration team leader for the Glaxo and Wellcome merger. Followingthis he then spent some time based in the US as SVP Finance and Operations forthe research and development operations of the merged business before becomingChief Financial Officer of Glaxo Wellcome Inc. During the merger with SmithKlineAdrian jointly led the integration team before becoming SVP Finance forGlaxoSmithKline R&D in 2001. He joined Invensys plc as Chief Financial Officerin 2002. About Smith & Nephew Smith & Nephew is a global medical technology business, specialising inOrthopaedics, Endoscopy and Advanced Wound Management products. Smith & Nephewis a global leader in arthroscopy and advanced wound management and is one ofthe fastest growing global orthopaedics companies. Smith & Nephew is dedicated to helping improve people's lives. The companyprides itself on the strength of its relationships with its surgeons andprofessional healthcare customers, with whom its name is synonymous with highstandards of performance, innovation and trust. The company has over 8,500employees and operates in 33 countries around the world generating annual salesof £1.25 billion. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Smith & Nephew